Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Opmaken van de balans: 11e Jaarsymposium Neurologie
jan 2017 | Hoofdpijn